FIRM PROFILE
LIFE CYCLE FIRMS
Morgan Lewis’s Life Sciences and Healthcare practice is one of the largest worldwide, and is specifically structured to provide comprehensive corporate, transactional, litigation, and regulatory legal services to clients of all sizes across all sectors of the industry. With over 275 lawyers, scientists and other technical specialists who focus on the life sciences and healthcare industry, including nearly 50 professionals with advanced life science degrees, Morgan Lewis has one of the largest practices in this area in the world. We stand apart from most other law firms in our scope and scale of lawyers and other professionals who understand and give practical advice regarding the issues that our clients face at any point along the entire product lifecycle pathway, from innovation to financing, development, approval and, ultimately, marketing and sale of new products, litigation, and transactions, and for all aspects of the healthcare industry. Our practice represents nearly 1,000 active global life sciences and healthcare clients throughout the US, Europe, and Asia, including most of the major pharmaceutical companies in the world, as well as numerous biotechnology companies, specialty pharma companies, medical device manu-facturers, food and food additive manufacturers, nutritional companies, healthcare providers and insurers, renowned research and scientific institutions, and life sciences-focused private equity firms and venture capital firms. As a result of our representation of all major sectors of the life sciences and healthcare industry, we can provide insights from our experiences with all of them in representation of particular clients. As a full-service firm with offices in the financial and regulatory centers of critical importance to the industry in the US, Europe and Asia, we are uniquely situated to provide assistance over the complete range of industry activities. Transactions We combine multi-office capabilities in M&A with industry experience in pharmaceuticals, biotechnology, medical devices, and other FDA-regulated products. We regularly handle transactions of all sizes, from mid-market deals to multi-billion dollar transactions. These deals include product and company acquisitions and divestitures, licensing and other collaboration agreements, negotiated business combinations by public and private companies, tender offers (friendly and hostile), proxy contests, restructurings, leveraged buyouts, and “going private” transactions. We also assist on FDA and CMS regulatory due diligence, on antitrust analysis of mergers and collaboration agreements, and obtaining clearances for acquisitions and joint ventures. Our team regularly works with and represents life sciences companies, investment banks and private equity firms, venture capital firms, institutional lenders, independent directors committees, and management groups. Regulatory Morgan Lewis’ FDA & healthcare attorneys represent life sciences and healthcare companies on a wide variety of regulatory, compliance, fraud and abuse, litigation, privacy, and health policy matters. We represent pharma, biologic, medical device and food/food additive manufacturers, suppliers, distributors, vendors, hospitals and health systems, clinical research organizations, and private equity companies focused on the life sciences and healthcare industry. Additionally, our attorneys, many with FDA, DOJ and OIG health care fraud government experience, provide compliance guidance and investigation representation. Our compliance and enforcement representations are globally focused, relating to worldwide clinical research and development, sales and marketing, and other business activities. Intellectual Property Morgan Lewis’s lawyers, patent agents, and technical specialists have experience in a diverse array of life sciences technologies. All of our patent lawyers and patent agents have science or engineering backgrounds, and many have advanced degrees in the life sciences. Many have worked as patent examiners at the US Patent and Trademark Office (USPTO) or have years of industry experience. We appear regularly before the USPTO and other relevant government agencies, as well as before the US Court of Appeals for the Federal Circuit. We combine the technical capabilities of our patent attorneys with the courtroom skills and strategies of our patent litigators. We also regularly counsel clients on all matters under the Hatch-Waxman Act and with respect to biosimilars, from developing patent procurement strategies to defending those strategies in litigation. Litigation Our litigation attorneys have been involved in life sciences and healthcare related litigation for more than three decades, bringing together the trial skills, industry experience, and legal knowledge needed to handle fraud and abuse, commercial, product liability, and insurance recovery matters in any jurisdiction. For life sciences and healthcare companies, our White-collar litigation lawyers regularly represent life sciences companies in fraud and abuse investigations and litigation. We also extensively represent healthcare insurers. Our Commercial litigation practitioners routinely represent companies as both plaintiffs’ and defense counsel in the full range of business disputes, including trade secrets and non-compete litigation, supplier/purchaser disputes, post-acquisition disputes, consumer-class actions and other consumer-related litigation, and third party payor cases. We have a longstanding, nationally recognized Product Liability Practice that has for decades successfully represented clients in class actions, individual lawsuits, and multidistrict matters. We frequently serve as national coordinating counsel and trial coun ??????????????????????????????????????????????????????=??%????????I????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????()15 ?1%?M
%9
L?????((???((